300
Views
4
CrossRef citations to date
0
Altmetric
Articles

A guanylurea ligand and its Cu(II), Ni(II) and Zn(II) complexes: antibacterial activities and DNA binding properties

, , &
Pages 627-635 | Received 02 Apr 2020, Accepted 21 Jun 2020, Published online: 03 Aug 2020
 

Abstract

New Cu(II), Ni(II), Zn(II) complexes of a guanylurea ligand were synthesized and their structures were characterized by spectroscopic and analytical methods. The ligand was prepared by the hydrolysis of dicyandiamine in the presence of glacial acetic acid and obtained as acetate salt (HL·OAc). Molecular structure of the ligand and its Cu(II) complex were determined by single crystal X-ray diffraction studies. In the structure of the Cu(II) complex, each Cu(II) ion is four-coordinate with an approximate square planar geometry. The structures of the ligand and its Cu(II) complex were stabilized by hydrogen bond interactions. Antibacterial activity of the complexes was evaluated by single disk method. The complexes exhibit antibacterial activity. The synthesized compounds were screened for their FSds-DNA properties and Zn(II) complex showed higher binding affinity than free ligand and its Cu(II) and Ni(II) complexes.

Additional information

Funding

The authors are grateful to the Turkish Council of Higher Education for the award (YOK 100/2000) of a postgraduate scholarship (to S.N.K.K. and O.G.).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.